The CD74 inhibitor DRhQ improves short-term memory and mitochondrial function in 5xFAD mouse model of Aβ accumulation

Antunes M, Biala G (2012) The novel object recognition memory: neurobiology, test procedure, and its modifications. Cogn Process 13(2):93–110

Article  PubMed  Google Scholar 

Bacher M, Deuster O, Aljabari B, Egensperger R, Neff F, Jessen F, Popp J, Noelker C, Reese JP, Al-Abed Y, Dodel R (2010) The role of macrophage migration inhibitory factor in Alzheimer’s disease. Mol Med 16(3–4):116–121

Benedek G, Zhu W, Libal N, Casper A, Yu X, Meza-Romero R, Vandenbark AA, Alkayed NJ, Offner H (2014) A novel HLA-DRalpha1-MOG-35-55 construct treats experimental stroke. Metab Brain Dis 29(1):37–45

Article  PubMed  PubMed Central  Google Scholar 

Benedek G, Vandenbark AA, Alkayed NJ, Offner H (2017) Partial MHC class II constructs as novel immunomodulatory therapy for stroke. Neurochem Int 107:138–147

Article  PubMed  Google Scholar 

Bengoetxea X, Rodriguez-Perdigon M, Ramirez MJ (2015) Object recognition test for studying cognitive impairments in animal models of Alzheimer’s disease. Front Biosci (Schol Ed) 7(1):10–29

Article  PubMed  Google Scholar 

Bolmont T, Haiss F, Eicke D, Radde R, Mathis CA, Klunk WE, Kohsaka S, Jucker M, Calhoun ME (2008) Dynamics of the microglial/amyloid interaction indicate a role in plaque maintenance. J Neurosci 28(16):4283–4292

Article  PubMed  PubMed Central  Google Scholar 

Bryan KJ, Zhu X, Harris PL, Perry G, Castellani RJ, Smith MA, Casadesus G (2008) Expression of CD74 is increased in neurofibrillary tangles in Alzheimer’s disease. Mol Neurodegener 3:13

Article  PubMed  PubMed Central  Google Scholar 

Burns A, Byrne EJ, Maurer K (2002) Alzheimer’s Disease. Lancet 360(9327):163–165

Article  PubMed  Google Scholar 

Culmsee C, Michels S, Scheu S, Arolt V, Dannlowski U, Alferink J (2019) Mitochondria, microglia, and the immune system—how are they linked in affective disorders?. Front Psych 9

Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, Littman DR, Dustin ML, Gan WB (2005) ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 8(6):752–758

Article  PubMed  Google Scholar 

De R, Sarkar S, Mazumder S, Debsharma S, Siddiqui AA, Saha SJ, Banerjee C, Nag S, Saha D, Pramanik S, Bandyopadhyay U (2018) Macrophage migration inhibitory factor regulates mitochondrial dynamics and cell growth of human cancer cell lines through CD74-NF-κB signaling. J Biol Chem 293(51):19740–19760

Article  PubMed  PubMed Central  Google Scholar 

Freedman M, Oscar-Berman M (1989) Spatial and visual learning deficits in Alzheimer’s and Parkinson’s disease. Brain Cogn 11(1):114–126

Article  PubMed  Google Scholar 

Fu XX, Duan R, Wang SY, Zhang QQ, Wei B, Huang T, Gong PY, Yan E, Jiang T, Zhang YD (2023) Lamotrigine protects against cognitive deficits, synapse and nerve cell damage, and hallmark neuropathologies in a mouse model of Alzheimer’s disease. Neural Regen Res 18(1):189–193

Article  PubMed  Google Scholar 

Guarino A, Favieri F, Boncompagni I, Agostini F, Cantone M, Casagrande M (2018) Executive functions in alzheimer disease: a aystematic review. Front Aging Neurosci 10:437

Article  PubMed  Google Scholar 

Hanisch UK, Kettenmann H (2007) Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10(11):1387–1394

Article  PubMed  Google Scholar 

Hansen DV, Hanson JE, Sheng M (2018) Microglia in alzheimer’s disease. J Cell Biol 217(2):459–472

Article  PubMed  PubMed Central  Google Scholar 

Hardy JA, Higgins GA (1992) Alzheimer’s disease: the amyloid cascade hypothesis. Science 256(5054):184–185

Article  PubMed  Google Scholar 

Leng F, Edison P (2021) Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Reviews Neurol 17(3):157–172

Article  Google Scholar 

Li Y, Xia X, Wang Y, Zheng JC (2022) Mitochondrial dysfunction in microglia: a novel perspective for pathogenesis of Alzheimer’s disease. J Neuroinflammation 19(1):248

Article  PubMed  PubMed Central  Google Scholar 

Loftis JM, Wilhelm CJ, Vandenbark AA, Huckans M (2013) Partial MHC/neuroantigen peptide constructs: a potential neuroimmune-based treatment for methamphetamine addiction. PLoS ONE 8(2):e56306

Article  PubMed  PubMed Central  Google Scholar 

Loftis JM, Navis T, Taylor J, Hudson R, Person U, Lattal KM, Vandenbark AA, Shirley R, Huckans M (2020) Partial MHC/neuroantigen peptide constructs attenuate methamphetamine-seeking and brain chemokine (C-C motif) ligand 2 levels in rats. Eur J Pharmacol 880:173175

Article  PubMed  PubMed Central  Google Scholar 

Matthews DG, Caruso M, Murchison CF, Zhu JY, Wright KM, Harris CJ, Gray NE, Quinn JF, Soumyanath A (2019) Centella asiatica improves memory and promotes antioxidative signaling in 5XFAD mice. Antioxidants (Basel) 8(12). https://pmc.ncbi.nlm.nih.gov/articles/PMC6943631/#sec2-antioxidants-08-00630

Maturana W, Lobo I, Landeira-Fernandez J, Mograbi DC (2023) Nondeclarative associative learning in Alzheimer’s disease: an overview of eyeblink, fear, and other emotion-based conditioning. Physiol Behav 268:114250

Article  PubMed  Google Scholar 

Meza-Romero R, Benedek G, Jordan K, Leng L, Pantouris G, Lolis E, Bucala R, Vandenbark AA (2016) Modeling of both shared and distinct interactions between MIF and its homologue D-DT with their common receptor CD74. Cytokine 88:62–70

Article  PubMed  PubMed Central  Google Scholar 

Meza-Romero R, Benedek G, Gerstner G, Kent G, Nguyen H, Offner H, Vandenbark AA (2019) Increased CD74 binding and EAE treatment efficacy of a modified DRalpha1 molecular construct. Metab Brain Dis 34(1):153–164

Article  PubMed  Google Scholar 

Nasiri E, Sankowski R, Dietrich H, Oikonomidi A, Huerta PT, Popp J, Al-Abed Y, Bacher M (2020) Key role of MIF-related neuroinflammation in neurodegeneration and cognitive impairment in Alzheimer’s disease. Mol Med 26(1):34

Article  PubMed  PubMed Central  Google Scholar 

NIoH N (2021) Alzheimer’s disease fact sheet. Alzheim Dis Educ Referral Cent

Oyama R, Yamamoto H, Titani K (2000) Glutamine synthetase, hemoglobin alpha-chain, and macrophage migration inhibitory factor binding to amyloid beta-protein: their identification in rat brain by a novel affinity chromatography and in Alzheimer’s disease brain by immunoprecipitation. Biochim Biophys Acta 1479(1–2):91–102

Article  PubMed  Google Scholar 

Padua MS, Guil-Guerrero JL, Lopes PA (2024) Behaviour hallmarks in alzheimer’s disease 5xFAD mouse model. Int J Mol Sci 25(12)

Quinn JF, Bussiere JR, Hammond RS, Montine TJ, Henson E, Jones RE, Stackman RW Jr. (2007) Chronic dietary alpha-lipoic acid reduces deficits in hippocampal memory of aged Tg2576 mice. Neurobiol Aging 28(2):213–225

Article  PubMed  Google Scholar 

Salmon DP, Heindel WC, Hamilton JM, Vincent Filoteo J, Cidambi V, Hansen LA, Masliah E, Galasko D (2015) Recognition memory span in autopsy-confirmed dementia with Lewy Bodies and Alzheimer’s Disease. Neuropsychologia 75:548–555

Article  PubMed  PubMed Central  Google Scholar 

Stothart G, Smith LJ, Milton A, Coulthard E (2021) A passive and objective measure of recognition memory in Alzheimer’s disease using fastball memory assessment. Brain 144(9):2812–2825

Article  PubMed  PubMed Central  Google Scholar 

Streit WJ, Braak H, Del Tredici K, Leyh J, Lier J, Khoshbouei H, Eisenlöffel C, Müller W, Bechmann I (2018) Microglial activation occurs late during preclinical Alzheimer’s disease. Glia 66(12):2550–2562

Article  PubMed  Google Scholar 

Sumaiya K, Langford D, Natarajaseenivasan K, Shanmughapriya S (2022) Macrophage migration inhibitory factor (MIF): a multifaceted cytokine regulated by genetic and physiological strategies. Pharmacol Ther 233:108024

Article  PubMed  Google Scholar 

Vandenbark AA et al (2013) A novel regulatory pathway for autoimmune disease: binding of partial MHC class II constructs to monocytes reduces CD74 expression and induces both specific and bystander T-cell tolerance. J Autoimmun 40:96–110. https://doi.org/10.1016/j.jaut.2012.08.004

Vandenbark AA, Meza-Romero R, Benedek G, Offner H (2019) A novel neurotherapeutic for multiple sclerosis, ischemic injury, methamphetamine addiction, and traumatic brain injury. J Neuroinflammation 16(1):14

Article  PubMed  PubMed Central  Google Scholar 

Vandenbark AA, Meza-Romero R, Wiedrick J, Gerstner G, Seifert H, Kent G, Piechycna M, Benedek G, Bucala R, Offner H (2022) Near cure treatment of severe acute EAE in MIF-1-deficient female and male mice with a bifunctional MHCII-derived molecular construct. Cell Immunol 378:104561

Article  PubMed  PubMed Central  Google Scholar 

Verri, M., O. Pastoris, M. Dossena, R. Aquilani, F. Guerriero, G. Cuzzoni, L. Venturini,G. Ricevuti and A. I. Bongiorno (2012). Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimer’s disease. Int J Immunopathol Pharmacol 25(2): 345–353

留言 (0)

沒有登入
gif